Table 2. Histopathological classification and clinic features of the malignant tumor.
Type of malignant tumor | Cases | All malignant tumor (%) | Subtype tumor (%) | All tumor (%) | Mean age (range), y | Sex (F/M) | Location (U/L) |
Tumors of the epidermis (180, 61.7%) | |||||||
Basal cell carcinoma | 165 | 56.5 | 15.3 | 7.4 | 63 (12-85) | 0.9/1 | 0.3/1 |
Squamous cell carcinoma | 11 | 3.8 | 1 | 0.5 | 58 (40-80) | 1.2/1 | 1.8/1 |
Papillary squamous cell carcinoma | 2 | 0.7 | 0.2 | 0.09 | 65 (54-76) | 1/1 | 1/1 |
Basosquamous carcinoma | 2 | 0.7 | 0.2 | 0.09 | 53 (49-57) | 0/2 | 1/1 |
Adnexal tumors (101, 34.6%) | |||||||
Sebaceous gland carcinoma | 101 | 34.6 | 38.4 | 4.5 | 60 (20-98) | 1.9/1 | 2.1/1 |
Miscellaneous tumors (11, 3.8%) | |||||||
Lymphoid and metastatic tumors | 5 | 1.7 | 0.6 | 0.2 | 61 (35-71) | 0.7/1 | 4/1 |
Melanocytic tumors | 4 | 1.4 | 0.5 | 0.2 | 66 (32-83) | 1/1 | 3/1 |
Tumors of neural crest origin | 2 | 0.7 | 0.2 | 0.09 | 85 (84-85) | 1/1 | 0/2 |
F/M: Female/male; U/L: Upper/lower eyelid.